BackgroundEstablishing the value of differing treatments for depression and anxiety is crucial in a climate of delimited spending and increased demand. Drawing from a well‐founded, diverse evidence base is salient to constructive evaluation and any subsequent recommendations being fit for purpose.DesignThis study employed a practice‐based quantitative design to explore therapeutic gains in adult counselling clients attending person‐centred therapy (n = 301), delivered in a charitable, community‐based UK service.MeasuresOutcome measures PHQ‐9 and GAD‐7 were used from three time points: initial assessment (IA), first ongoing session and last or 6th ongoing appointment (whichever occurred first; T1, T2 and T3).AnalysisRepeated measures ANOVA, CSI, RI and RCSI calculations were used to consider significant change in clients.FindingsReductions in PHQ‐9 and GAD‐7 outcome measures were observed over time (between T2 & T3 and T1 & T3) and were all statistically significant (p = <0.001). By T3: CSI was achieved by 48.1% of clients on PHQ‐9 and 50.8% of clients on GAD‐7, RI was achieved by 47.8% of clients on PHQ‐9 and 60.5% of clients on GAD‐7, and RCSI was achieved by 32.6% of clients on PHQ‐9 and 41.2% of clients on GAD‐7.ConclusionsThe treatment observed resulted in effective outcomes equivalent to other therapies reviewed in the literature for clients' symptoms of anxiety and depression as measured by GAD‐7 and PHQ‐9.